Showing results (4041-4050 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|May 8, 2023
Pancreatic Enzyme Replacement and Nutritional Support With n ab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic CancerGuido Giordano, Raffaele Ivan Cincione, Francesca Losavio, et al.
The Oncologist|May 9, 2023
Suspected Germline TP53 Variants and Clonal Hematopoiesis of Indeterminate Potential: Lessons Learned From a Molecular Tumor BoardCamila B Xavier, Rudinei Link, Leonília Abreu, et al.
The Oncologist|May 17, 2023
Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic AncestryTaylor Peak, Philippe E Spiess, Roger Li, et al.
The Oncologist|April 29, 2023
Race/Ethnicity and Gender Representation in Hematology and Oncology Editorial Boards: What is the State of Diversity?Shruti R Patel, Ivy Riano, Inas Abuali, et al.
The Oncologist|April 29, 2023
Dramatic Response to Pyrotinib and T-DM1 in HER2-Negative Metastatic Breast Cancer With 2 Activating HER2 MutationsHao Tian, Man Qu, Guozhi Zhang, et al.
The Oncologist|May 4, 2023
Response to Pralsetinib in Multi-Drug-Resistant Breast Cancer With CCDC6-RET MutationJing Zhao, Wei Xu, Xiaoli Zhuo, et al.
The Oncologist|May 4, 2023
The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal CancerAna Fernández Montes, Vicente Alonso Orduña, Elena Asensio Martínez, et al.
The Oncologist|May 4, 2023
Humoral Immunity After COVID-19 Vaccination in Chronic Lymphocytic Leukemia and Other Indolent Lymphomas: A Single-Center Observational StudyPeter G Doukas, Frederique St Pierre, Reem Karmali, et al.
The Oncologist|August 20, 2020
Safety and Efficacy of Andecaliximab (GS-5745) Plus Gemcitabine and Nab-Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I StudyJohanna Bendell, Sunil Sharma, Manish R Patel, et al.
The Oncologist|April 3, 2023
A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid TumorsMeredith LaRose, Roisin M Connolly, Ciara C O'Sullivan, et al.
Pageof 571